We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$14.9B
AUM Growth
+$995M
Cap. Flow
-$291M
Cap. Flow %
-1.95%
Top 10 Hldgs %
26.38%
Holding
2,856
New
31
Increased
336
Reduced
1,500
Closed
71

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$28.4M
2
MSFT icon
Microsoft
MSFT
+$25.6M
3
NVDA icon
NVIDIA
NVDA
+$15.2M
4
AMZN icon
Amazon
AMZN
+$11.2M
5
IWM icon
iShares Russell 2000 ETF
IWM
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 27.53%
2 Financials 12.17%
3 Healthcare 11.68%
4 Consumer Discretionary 10.99%
5 Industrials 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVEC icon
2126
NVE Corp
NVEC
$563M
$228K ﹤0.01%
2,523
CGEM icon
2127
Cullinan Oncology
CGEM
$1.26B
$227K ﹤0.01%
13,337
ATEX icon
2128
Anterix
ATEX
$1.79B
$227K ﹤0.01%
6,751
SBGI icon
2129
Sinclair Inc
SBGI
$1.03B
$227K ﹤0.01%
16,841
CVLG icon
2130
Covenant Logistics
CVLG
$880M
$227K ﹤0.01%
9,776
SEE
2131
DELISTED
Sealed Air
SEE
$226K ﹤0.01%
6,088
+18
+0.3% +$645
RUSHB icon
2132
Rush Enterprises Class B
RUSHB
$9.37B
$226K ﹤0.01%
4,249
RSI icon
2133
Rush Street Interactive
RSI
$2.85B
$226K ﹤0.01%
34,711
PGC icon
2134
Peapack-Gladstone Financial
PGC
$822M
$226K ﹤0.01%
9,287
DENN
2135
DELISTED
Denny's
DENN
$225K ﹤0.01%
25,157
-4,595
-15% -$45.1K
CENT icon
2136
Central Garden & Pet Co
CENT
$2.78B
$225K ﹤0.01%
5,256
-1,314
-20% -$53.6K
GDOT icon
2137
Green Dot
GDOT
$770M
$225K ﹤0.01%
24,083
-846
-3% -$7.46K
LAND
2138
Gladstone Land Corp
LAND
$358M
$224K ﹤0.01%
16,827
MCBS icon
2139
MetroCity Bankshares
MCBS
$1.05B
$224K ﹤0.01%
8,982
MRSN
2140
DELISTED
Mersana Therapeutics
MRSN
$224K ﹤0.01%
1,996
+130
+7% +$12.9K
AMAL icon
2141
Amalgamated Financial
AMAL
$1.53B
$223K ﹤0.01%
9,310
INST
2142
DELISTED
Instructure Holdings, Inc.
INST
$223K ﹤0.01%
10,449
RARE icon
2143
Ultragenyx Pharmaceutical
RARE
$2.6B
$223K ﹤0.01%
4,779
+15
+0.3% +$708
TIPT icon
2144
Tiptree Inc
TIPT
$677M
$222K ﹤0.01%
12,854
OWL icon
2145
Blue Owl Capital
OWL
$19.7B
$220K ﹤0.01%
11,688
+30
+0.3% +$503
NPK icon
2146
National Presto Industries
NPK
$987M
$220K ﹤0.01%
2,628
SRDX
2147
DELISTED
Surmodics
SRDX
$220K ﹤0.01%
7,505
RPRX icon
2148
Royalty Pharma
RPRX
$26.1B
$220K ﹤0.01%
7,244
+17
+0.2% +$501
WEAV icon
2149
Weave Communications
WEAV
$426M
$219K ﹤0.01%
19,117
URGN icon
2150
UroGen Pharma
URGN
$2.34B
$219K ﹤0.01%
14,626

Similar funds

MetLife Investment Management's Q1 2024 Portfolio in Review

As of Q1 2024, MetLife Investment Management held 2,856 positions worth $14.9B, up 7.2% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3.6%. MetLife Investment Management opened 31 new positions and exited 71, leaving the 2,856-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q1 2024 buy was Flutter Entertainment: 9,898 shares worth $1.98M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q1 2024, an estimated $128M increase.
  • MetLife Investment Management's biggest Q1 2024 reduction was Apple, cutting an estimated $28.4M.
  • MetLife Investment Management fully exited Immunogen Inc in Q1 2024, selling an estimated $3.72M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $14.9B portfolio in Q1 2024.
  • MetLife Investment Management opened 31 new positions and closed 71 in Q1 2024.
  • MetLife Investment Management's portfolio value rose 7.2% quarter-over-quarter to $14.9B.

Based on MetLife Investment Management's 13F filing for Q1 2024, filed 14 May 2024.